RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.94B
AUM Growth
-$52.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
90
New
Increased
Reduced
Closed

Top Buys

1
+$111M
2
+$29.3M
3
+$27.4M
4
HNGE
Hinge Health
HNGE
+$15.5M
5
TYRA icon
Tyra Biosciences
TYRA
+$14.9M

Top Sells

1
+$58.6M
2
+$46.8M
3
+$45.6M
4
URGN icon
UroGen Pharma
URGN
+$35.5M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$33.1M

Sector Composition

1 Healthcare 99.82%
2 Financials 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOWL icon
51
Werewolf Therapeutics
HOWL
$26.7M
$7.28M 0.12%
6,681,307
+536,426
BBNX
52
Beta Bionics
BBNX
$783M
$7.28M 0.12%
500,000
CTMX icon
53
CytomX Therapeutics
CTMX
$720M
$6.04M 0.1%
2,661,331
+1,661,331
TXG icon
54
10x Genomics
TXG
$2.68B
$5.5M 0.09%
475,343
-1,468,904
SRZN icon
55
Surrozen
SRZN
$171M
$5.39M 0.09%
602,626
-76,504
WGS icon
56
GeneDx Holdings
WGS
$3.16B
$5.36M 0.09%
+58,044
AVTX icon
57
Avalo Therapeutics
AVTX
$290M
$4.66M 0.08%
932,973
-34,027
ACET icon
58
Adicet Bio
ACET
$76.2M
$4.6M 0.08%
471,313
MBX
59
MBX Biosciences
MBX
$1.84B
$4.31M 0.07%
377,841
-1,133,493
TARA icon
60
Protara Therapeutics
TARA
$270M
$3.15M 0.05%
1,039,295
-2,360,705
NAMSW icon
61
NewAmsterdam Pharma Warrant
NAMSW
$93.2M
$2.67M 0.04%
333,333
ACHC icon
62
Acadia Healthcare
ACHC
$1.08B
$2.03M 0.03%
89,262
-127,738
IFRX icon
63
InflaRx
IFRX
$67.7M
$1.56M 0.03%
+1,973,233
ACRS icon
64
Aclaris Therapeutics
ACRS
$289M
– –
-4,666,667
ALEC icon
65
Alector
ALEC
$199M
– –
-9,695,228
APGE icon
66
Apogee Therapeutics
APGE
$5.52B
– –
-1,569,491
ATXS icon
67
Astria Therapeutics
ATXS
$731M
– –
-5,105,213
BCYC
68
Bicycle Therapeutics
BCYC
$449M
– –
-1,093,477
DAWN icon
69
Day One Biopharmaceuticals
DAWN
$1.08B
– –
-5,755,577
DRUG
70
Bright Minds Biosciences
DRUG
$875M
– –
-206,427
EYPT icon
71
EyePoint Inc
EYPT
$1.31B
– –
-3,181,818
GKOS icon
72
Glaukos
GKOS
$6.58B
– –
-190,256
HUMA icon
73
Humacyte
HUMA
$212M
– –
-3,312,356
IDYA icon
74
IDEAYA Biosciences
IDYA
$3.16B
– –
-1,347,252
IMTX icon
75
Immatics
IMTX
$1.33B
– –
-1,750,000
1 2
3
4